BACKGROUND: Adenocarcinoma in situ of the uterine cervix is a precursor to cervical adenocarcinoma and may coexist with both adenocarcinoma and high-grade squamous dysplasia (cervical intraepithelial neoplasia 2 and 3). Up to 60% of adenocarcinoma in situ lesions are detected incidentally following excisional biopsies performed for the treatment of cervical intraepithelial neoplasia 2/3. To date there are no data regarding risk factors for persisting or progressive cervical neoplasia in these patients. OBJECTIVE: We sought to investigate patient outcomes following incidentally detected cervical adenocarcinoma in situ after loop electrosurgical excision procedure or cold knife cone biopsy performed for the treatment of high-grade cervical intraepithelial neoplasia. STUDY DESIGN: We conducted a retrospective, population-based cohort study of Western Australian patients with an incidental diagnosis of adenocarcinoma in situ from 2001 through 2012. Primary outcomes were persistent or recurrent cervical intraepithelial neoplasia 2/3 and or adenocarcinoma in situ, and invasive adenocarcinoma during follow-up (<12 months) and surveillance (12 months) periods.
Introduction
Adenocarcinoma in situ (AIS) of the uterine cervix is a precursor to cervical adenocarcinoma 1, 2 and may coexist with both adenocarcinoma and high-grade squamous dysplasia (cervical intraepithelial neoplasia [CIN] 2 and 3). [3] [4] [5] [6] [7] [8] Following the diagnosis of AIS on screening cytology or cervical biopsy, an excisional procedure such as a cold knife cone (CKC) biopsy or loop electrosurgical excision procedure (LEEP) is mandatory to exclude invasive disease. 3, 6, 7, 9 Because AIS is most prevalent in women <40 years of age such procedures may be considered adequate treatment in women desiring fertility preservation providing margins are clear. 5, [8] [9] [10] [11] [12] [13] Many patients with AIS are asymptomatic with the diagnosis often being made on routine cervical screening. 11, [14] [15] [16] [17] However, up to 60% of AIS lesions are detected incidentally following clinical examination for CIN 2/3. [15] [16] [17] [18] The 2012 Canadian Colposcopic Management of Abnormal Cervical Cytology and Histology clinical practice guidelines recommend careful assessment of margins when AIS is found incidentally in a LEEP biopsy performed for CIN. 3 These guidelines do not advocate a repeated excisional procedure providing that the glandular (AIS) lesion is small, margins are clear, and fertility preservation is desired by the patient. 3 However, lesion size is not specified and therefore it is unclear what is meant by "small." More generally, to our knowledge, there are no data determining risk factors for persisting or progressive cervical neoplasia in these patients.
Since data determining the optimal management of women with incidentally detected AIS are lacking, 18 in the current study we aimed to investigate the risk of persistent/recurrent cervical neoplasia in such women in a large population-based cohort in Western Australia (WA).
Materials and Methods

Data sources and linkage procedure
The WA Data Linkage System is an internationally recognized and validated data linkage system that facilitates person-level linkage of records in various state health-related populationbased data sets. 19, 20 The Cervical Screening Registry (CSR) of WA is legislatively required to record all cervical test results (human papillomavirus [HPV] , cytology, and histology) for WA residents. The CSR is an opt-off register with <0.05% of women requesting the removal of their demographic information and cervical test results. 5 
Selection of patients
Histopathology findings
All histopathology reports were reviewed to confirm the type of excisional biopsy (CKC biopsy or LEEP), number of surgical specimens, depth of the specimen, presence of concurrent high-grade CIN, and resection margin status. The number of surgical specimens was classified as 1 or >1, the latter including both intentional 2-stage procedures (LEEP followed by "top-hat" endocervical sampling) as well as technically difficult procedures that resulted in multiple, fragmented, or incomplete specimens. Margin status was considered positive if any margin (ectocervical, endocervical, or deep/circumferential) was involved by CIN 2/3 and/or AIS; negative if all margins were histologically clear of in situ disease; and indeterminate if margins could not be assessed or were not documented. The extent of AIS was determined whenever possible from the initial histopathology reports in 1 of 2 ways. In some specimens, the maximal extent of AIS was specifically documented while in other cases the number of tissue blocks demonstrating AIS was recorded; in the latter situation, AIS extent was estimated assuming a standard block width of 2.5 mm multiplied by the total number of involved blocks. 22 In the event that the lesion size and/or number of positive blocks was not reported, the specimens were recorded as: lesion size not reported. For those cases with reported AIS extent, the lesion size was categorized as: <1.5, 1.5-2.0, >2.0-2.5, >2.5-5, >5-8, or >8 mm.
Follow-up
Subsequent follow-up of patients potentially included cytological review, repeat CKC or LEEP biopsy, and/or hysterectomy. The follow-up period was defined as the date of the initial excisional procedure to the date of the last follow-up procedure (eg, cervical cytology, biopsy, or hysterectomy) or death. Original Research GYNECOLOGY ajog.org
Principal outcomes
The principal outcomes to be ascertained were: (1) persistence of CIN 2/3 or AIS, or a diagnosis of adenocarcinoma during the follow-up period (defined as <12 months after initial diagnosis); and (2) recurrence of CIN 2/3 or AIS, or a diagnosis of adenocarcinoma within the surveillance period (defined as 12 months after initial diagnosis).
Statistics
Kaplan-Meier graphs were constructed to investigate the survivorship function (time from initial excisional procedure until biopsy-confirmed high-grade cervical neoplasia persistence or recurrence), and log-rank tests were used to assess equality of the survivorship function. Proportional hazards models were constructed after simultaneously adjusting for multiple factors to investigate the relative rate (hazard ratio) of having, or subsequently developing, a high-grade cervical lesion after initial treatment. Models were constructed using purposeful selection of covariates including age at treatment, type of excisional procedure (CKC biopsy or LEEP), margin status, lesion size, and depth of excised tissue. Statistical significance was determined as a P value <.05 and the 95% confidence intervals (CI) for hazard rate ratios were calculated. Violation of the proportional hazard assumptions was assessed and biologically plausible interaction terms between variables were tested. Software (Stata/IC 13.0; StataCorp LP, College Station, TX) was used for statistical analysis.
Results
Study cohort
During the study period 345 patients undergoing excisional treatment for CIN 2/3 had an incidental finding of AIS. In all, 47 patients were excluded from further analysis because screening history or follow-up was not available, or because the patients underwent hysterectomy (Figure 1 ). For the remaining 298 patients, the mean age was 31.2 (range 18-68) years and median followup interval was 2.4 (range 0.3-12.2) years. Baseline patient demographics showed subjects categorized according to measures of social advantage or disadvantage were evenly distributed (Table 1) .
AIS lesion size could be ascertained in 152 (51%) cases (Table 1) of which 74 were directly measured and 78 determined from the number of involved blocks. The median lesion size was 2.5 (range 0.4-22.5) mm (Table 1) . Second excisional procedure specimens revealed a range of histopathology outcomes among subjects with persistent disease when compared to initial margin status (Table 2) .
Follow-up period (<12 months posttreatment)
In the 12 months following the initial CKC or LEEP biopsy, 108 (36.2%) patients had a second excisional procedure; 66 were due to positive margins in the initial excision specimen and 42 were due to high-grade cervical cytology and/or cervical biopsy or abnormal/ unsatisfactory colposcopy during follow-up. Of the 108 patients who underwent a second excisional procedure or hysterectomy, 70 had negative findings, 10 had low-grade changes, 7 had CIN 2/3, 19 had AIS, and 2 had invasive adenocarcinoma (Table 2) . Of the 19 cases with persistent AIS, 11 (57.9%) had positive pathological margins in the original treatment specimen. There were 178 (59.7%) patients who underwent cervical surveillance (cytology and/or cervical biopsy), which was negative in 151 patients, showed a low-grade abnormality in 24, and a high-grade abnormality in 3 patients for whom there were no data regarding a further excisional procedure. The remaining 12 patients did not have a cervical test result recorded in this period.
Surveillance period ( ‡12 months posttreatment)
After excluding the 28 patients treated with a second excisional procedure in the follow-up period-up and a further 39 patients who had a hysterectomy (hysterectomy specimen reported 35 cases as ajog.org GYNECOLOGY Original Research negative and 4 with low-grade changes), a total of 231 patients entered into the surveillance period. Of these 231 patients, 16 (6.9%) underwent a second excisional procedure or hysterectomy (12 months posttreatment). Negative findings were recorded in 10 patients, 1 had low-grade changes, 2 had CIN 2/3, and 4 had recurrent AIS (Table 2) . One patient who underwent a second excisional procedure for recurrent AIS was subsequently diagnosed with adenocarcinoma when a hysterectomy was performed.
A further 18 patients had a cervical punch biopsy performed (12 cases were negative, 4 had low-grade changes, and 2 had CIN 2/3). A hysterectomy was performed for an additional 3 patients (all 3 cases were negative) in the surveillance period. A total of 162 patients underwent cervical surveillance (cervical screening), which was either negative (147 patients) or showed only low-grade abnormalities (15 patients) and 32 patients did not have a cervical test result recorded in the surveillance period. Overall, 11 (3.7%) patients had CIN 2/3, 23 (7.7%) had AIS, and 3 (1.0%) had adenocarcinoma diagnosed during the follow-up and surveillance periods.
Adenocarcinoma
Overall there were 3 cases of invasive cervical adenocarcinoma detected in the follow-up and surveillance study periods. All 3 patients had a LEEP performed initially and their specimens were submitted in multiple fragments making pathological assessment difficult. In each case, extensive AIS was reported and AIS was reported to involve the biopsy margins. Pure AIS was present for 2 of the 3 cancer cases. All patients subsequently underwent a second excisional procedure that reported the presence of adenocarcinoma.
Significant factors associated with disease persistence and recurrence
A Kaplan-Meier graph shows that 10% of patients had disease persistence within 12 months of initial treatment (Figure 2) . Kaplan-Meier graphs are also presented for margin status (Figure 3 ) and AIS lesion type (Figure 4 ).
Factors associated with disease persistence and recurrence were age >30 years at treatment (hazard rate ratio, 2.2; 95% CI, 1.09e4.27), a pure AIS lesion (hazard rate ratio, 3.2; 95% CI, 1.48e6.90); and lesion size >8 mm (hazard rate ratio, 4.8; 95% CI, 1.21e18.92) ( Table 2 ). Patient Socioeconomic Indexes for Areas were not identified as significantly associated with disease persistence or recurrence and were excluded from the final statistical model.
Comment
To our knowledge, this study is the largest investigation into outcomes for women with incidentally detected AIS following excisional treatment performed for high-grade CIN. Overall, persistent or recurrent high-grade in situ disease (AIS or CIN 2/3) was identified in 11.8% of the patient cohort [AIS (n ¼ 23) or CIN 2/3 (n ¼ 11)] and invasive adenocarcinomas in 3 cases (1.0%) with almost all occurring within the first 12 months following the initial excisional procedure.
Our findings are consistent with the results reported by Costa et al, 23 where older age was significantly associated with persistent/recurrent disease. A 2014 systematic review reported overall rates of AIS persistence/recurrence of 6-29%. 24 In a WA cohort of 338 patients treated for AIS from 2001 through 2012 with a median follow-up interval of 3.6 years, AIS persistence/recurrence was reported in 27 women (8%). 5 Up to 55% of AIS cases may coexist with a high-grade squamous intraepithelial lesion. 7 In the current study, pure AIS lesions (absence of coexistent CIN 2/3) detected incidentally on an excision specimen had an increased risk of disease persistence/recurrence when compared to mixed lesions (presence of coexistent CIN 2/3). This finding is notable and consistent with that of Song et al, 25 who reported that patients diagnosed with a mixed cervical AIS lesion (CIN 2/3 present) following cone biopsy had a more favorable prognosis than patients with pure AIS. Original Research GYNECOLOGY ajog.org An important finding in our study was that an AIS lesion >8 mm in extent strongly correlated with persistence/ recurrence. Consistent with the Canadian guidelines, 3 our findings suggest that smaller incidental AIS lesions (<8 mm) with clear margins do not require repeated excision, although this requires validation in larger prospective studies. Lesion size was recorded in only 51% of patients in our study because it is not mandatory for pathologists in Australia to report this. Prospective inclusion of AIS lesion size in excisional biopsy specimens would likely enhance our understanding of persistence/recurrence risk and inform future management guidelines. There were no significant differences in AIS persistence/recurrence by socioeconomic status, specimen depth, or treatment modality (CKC vs LEEP).
Limitations of the current study include the selection bias inherent in its retrospective design, the relatively short median follow-up interval (2.4 years), and ascertainment bias. A further limitation is the absence of HPV data.
However, legislative requirements for the reporting of cervical histopathology to the WA registry would have resulted in the capture of almost all incident cases. Furthermore, the state-based registry utilizes appropriate quality-assurance processes to minimize error and ensure completeness of the data. 5, 21 Valuable strengths of this study include the large size (298 cases) and population-based nature of the cohort.
In summary, following an incidental diagnosis of AIS, patient age >30 years, pure AIS lesions, and lesions >8 mm in extent were significantly associated with persistence/recurrence of AIS and/or CIN 2/3. These findings require further validation, but future guidelines for the management of in situ cervical neoplasia might consider "incidental AIS" as a separate category if it is demonstrated in prospective studies to have improved outcomes compared to cytologically detected AIS lesions.
In this study, incidental AIS was associated with a lower risk of persistence/recurrence.
Hence, younger women with incidental AIS lesions desiring conservative treatment, and especially those with coexisting CIN 2/3 and AIS lesions <8 mm in extent with clear margins, may not require immediate reexcision. Such patients should be counseled regarding the risk of AIS persistence/recurrence and the requirement to have colposcopy and a cervical screening test performed 6 months after treatment (for 1-2 years) and then remain under surveillance with routine cervical screening and HPV testing. 3, 26, 27 In older women no longer desiring fertility preservation, hysterectomy may be considered as a definitive treatment option until prospective randomized data are available to better inform practice.
n
